These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and Evolution. Grimm D; Büning H Hum Gene Ther; 2017 Nov; 28(11):1075-1086. PubMed ID: 28835125 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses. Grimm D; Lee JS; Wang L; Desai T; Akache B; Storm TA; Kay MA J Virol; 2008 Jun; 82(12):5887-911. PubMed ID: 18400866 [TBL] [Abstract][Full Text] [Related]
7. Tracking Adeno-Associated Virus Capsid Evolution by High-Throughput Sequencing. de Alencastro G; Pekrun K; Valdmanis P; Tiffany M; Xu J; Kay MA Hum Gene Ther; 2020 May; 31(9-10):553-564. PubMed ID: 32024384 [TBL] [Abstract][Full Text] [Related]
8. Directed evolution of adeno-associated virus (AAV) as vector for muscle gene therapy. Yang L; Li J; Xiao X Methods Mol Biol; 2011; 709():127-39. PubMed ID: 21194025 [TBL] [Abstract][Full Text] [Related]
9. Next-generation AAV vectors for clinical use: an ever-accelerating race. Weinmann J; Grimm D Virus Genes; 2017 Oct; 53(5):707-713. PubMed ID: 28762205 [TBL] [Abstract][Full Text] [Related]
10. Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants. Rapti K; Maiakovska O; Becker J; Szumska J; Zayas M; Bubeck F; Liu J; Gerstmann E; Krämer C; Wiedtke E; Grimm D J Vis Exp; 2022 Oct; (188):. PubMed ID: 36342179 [TBL] [Abstract][Full Text] [Related]
11. Production, Processing, and Characterization of Synthetic AAV Gene Therapy Vectors. El Andari J; Grimm D Biotechnol J; 2021 Jan; 16(1):e2000025. PubMed ID: 32975881 [TBL] [Abstract][Full Text] [Related]
12. Transposon-based mutagenesis generates diverse adeno-associated viral libraries with novel gene delivery properties. Koerber JT; Schaffer DV Methods Mol Biol; 2008; 434():161-70. PubMed ID: 18470644 [TBL] [Abstract][Full Text] [Related]
13. Codon-Optimization of Wild-Type Adeno-Associated Virus Capsid Sequences Enhances DNA Family Shuffling while Conserving Functionality. Cabanes-Creus M; Ginn SL; Amaya AK; Liao SHY; Westhaus A; Hallwirth CV; Wilmott P; Ward J; Dilworth KL; Santilli G; Rybicki A; Nakai H; Thrasher AJ; Filip AC; Alexander IE; Lisowski L Mol Ther Methods Clin Dev; 2019 Mar; 12():71-84. PubMed ID: 30534580 [TBL] [Abstract][Full Text] [Related]
14. Relevance of Assembly-Activating Protein for Adeno-associated Virus Vector Production and Capsid Protein Stability in Mammalian and Insect Cells. Grosse S; Penaud-Budloo M; Herrmann AK; Börner K; Fakhiri J; Laketa V; Krämer C; Wiedtke E; Gunkel M; Ménard L; Ayuso E; Grimm D J Virol; 2017 Oct; 91(20):. PubMed ID: 28768875 [TBL] [Abstract][Full Text] [Related]
15. A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection. Yang L; Jiang J; Drouin LM; Agbandje-McKenna M; Chen C; Qiao C; Pu D; Hu X; Wang DZ; Li J; Xiao X Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3946-51. PubMed ID: 19234115 [TBL] [Abstract][Full Text] [Related]
18. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors. Shi W; Arnold GS; Bartlett JS Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765 [TBL] [Abstract][Full Text] [Related]